Innovating Works

BIOINTAXIS

Activa
FRATAXAV: Pre-clinical validation of a novel gene therapy for a rare disease in non-human primates: Integrati... BIOINTAXIS tramitó un HORIZON EUROPE: HORIZON-EIE-2022-SCALEUP-02 Founded in 2018, Biointaxis is an academic spin-off company established by a team of researchers lead by a woman Scientist from the Research...
2023-06-05 - 2024-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.